- Marketwired•last monthAdvanced Proteome Therapeutics Corporation Formulates Strategic Plan Featuring Novel Antibody Program
Advanced Proteome Therapeutics Corporation announces plans bearing on its site-specific protein modification technology as it applies to therapeutic antibodies. The high demand for...
- Marketwired•3 months agoAdvanced Proteome Therapeutics Corporation and Wilex Subsidiary Heidelberg Pharma Collaborate to Create Improved Cancer Therapeutics
WILEX AG and Advanced Proteome Therapeutics Corporation, Vancouver, Canada today announced that Heidelberg Pharma GmbH, Ladenburg, Germany, a subsidiary of Wilex AG, entered into a...
- Marketwired•3 months ago
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Advanced Proteome Therapeutics Corporation is pleased to announce that it has closed...
Advanced Proteome Therapeutics Corporation (APC.V)
TSXV - TSXV Delayed Price. Currency in CAD
|Day's Range||0.05 - 0.08|
|52wk Range||0.03 - 0.13|
|1y Target Est||N/A|
|P/E Ratio (ttm)||-12.50|
|Avg Vol (3m)||23,109|
|Dividend & Yield||N/A (N/A)|